International Edition
Latest News
Health

Allergy Immunotherapy Market: Growth, Trends & Forecast (2024-2033)

Allergy Immunotherapy Market Poised for Significant Growth, Reaching $4.9 Billion by 2033 The global allergy immunotherapy market is experiencing substantial growth, driven by a rising prevalence of allergic disorders and advancements in treatment options. Valued at $1.8 billion…

Allergy Immunotherapy Market: Growth, Trends & Forecast (2024-2033)

Allergy Immunotherapy Market Poised for Significant Growth, Reaching $4.9 Billion by 2033

The global allergy immunotherapy market is experiencing substantial growth, driven by a rising prevalence of allergic disorders and advancements in treatment options. Valued at $1.8 billion in 2023, the market is projected to reach $4.9 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2024 to 2033 . This growth is fueled by an increasing incidence of allergies and a shift towards personalized medicine.

Understanding Allergy Immunotherapy

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment designed to reduce sensitivity to allergens. It works by gradually introducing increasing amounts of the allergen into the patient’s system, typically through injections, sublingual tablets, or drops. This process helps the immune system become less reactive, reducing the severity and frequency of allergic reactions .

Allergic reactions occur when the immune system overreacts to harmless substances, triggering the production of immunoglobulin E (IgE) antibodies. Allergy immunotherapy shifts the immune response from an IgE-dominated pathway to a more regulated immune profile .

Market Segmentation and Key Trends

The allergy immunotherapy market is segmented by type, application, and distribution channel:

  • Type: Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)
  • Application: Allergic Rhinitis, Asthma, Food Allergy, and Others
  • Distribution Channel: Hospital Pharmacies, Retail and Online Pharmacies

In 2023, subcutaneous immunotherapy held the largest market share . SCIT is favored by allergists due to its sustained relief, even after treatment completion, and established safety profile.

Hospital pharmacies are the primary distributors of allergy immunotherapy, ensuring proper treatment administration, inventory management, and expert guidance .

Factors Driving Market Growth

Several factors contribute to the expansion of the allergy immunotherapy market:

  • Rising Prevalence of Allergies: An increase in allergy cases globally is a major driver.
  • Focus on Personalized Medicine: A growing emphasis on tailored treatment approaches is boosting demand .
  • Advancements in Immunotherapy: Ongoing research and development are leading to innovative treatments.

Regional Outlook

North America and Europe currently lead the allergy immunotherapy market due to high healthcare expenditure and advanced medical infrastructure. The Asia-Pacific region is expected to experience significant growth due to increasing healthcare investments and awareness of allergic conditions. Improvements in healthcare systems are also driving growth in Latin America, the Middle East, and Africa (LAMEA).

Key Players in the Market

The allergy immunotherapy market is competitive, with key players including:

  • Torii Pharmaceutical Co., Ltd.
  • Biomay AG
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Allovate, LLC
  • HAL Allergy Group
  • Jubliant Pharma
  • Leti Pharma
  • Merck KGaA
  • Stallergenes Greer

These companies are focusing on innovation, product portfolio expansion, strategic alliances, and geographic reach to strengthen their market positions.

Recent Developments

  • May 2024: ALK-Abelló A/S received European regulatory acceptance for its filing for ITULAZAX (tree sublingual allergy immunotherapy) for young children .
  • October 2021: Stallergenes Greer partnered with Aptar Pharma to develop a connected device and mobile app for patients undergoing sublingual immunotherapy .

Challenges and Opportunities

While the allergy immunotherapy market presents significant opportunities, the risk of side effects remains a challenge. However, ongoing advancements in immunotherapy treatments offer promising avenues for expansion and improved patient outcomes.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”